209 related articles for article (PubMed ID: 26299738)
1. [Potential of Cell-free Circulating DNA in Diagnosis of Cancer].
Kubaczková V; Sedlaříková L; Bešše L; Almaši M; Hájek R; Ševčíková S
Klin Onkol; 2015; 28(4):251-9. PubMed ID: 26299738
[TBL] [Abstract][Full Text] [Related]
2. Circulating Biomarkers for Prediction of Treatment Response.
Cappelletti V; Appierto V; Tiberio P; Fina E; Callari M; Daidone MG
J Natl Cancer Inst Monogr; 2015 May; 2015(51):60-3. PubMed ID: 26063889
[TBL] [Abstract][Full Text] [Related]
3. The clinical role of circulating free tumor DNA in gastrointestinal malignancy.
Howell JA; Khan SA; Knapp S; Thursz MR; Sharma R
Transl Res; 2017 May; 183():137-154. PubMed ID: 28056336
[TBL] [Abstract][Full Text] [Related]
4. Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection.
Pantel K
PLoS Med; 2016 Dec; 13(12):e1002205. PubMed ID: 28027295
[TBL] [Abstract][Full Text] [Related]
5. Role of Circulating Cell-Free DNA in Cancers.
Aarthy R; Mani S; Velusami S; Sundarsingh S; Rajkumar T
Mol Diagn Ther; 2015 Dec; 19(6):339-50. PubMed ID: 26400814
[TBL] [Abstract][Full Text] [Related]
6. Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids.
Lewis JM; Heineck DP; Heller MJ
Expert Rev Mol Diagn; 2015; 15(9):1187-200. PubMed ID: 26189641
[TBL] [Abstract][Full Text] [Related]
7. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
[TBL] [Abstract][Full Text] [Related]
8. New markers for cancer detection.
Wong IH; Lo YM
Curr Oncol Rep; 2002 Nov; 4(6):471-7. PubMed ID: 12354358
[TBL] [Abstract][Full Text] [Related]
9. Liquid Biopsy: Is There an Advantage to Analyzing Circulating Exosomal DNA Compared to cfDNA or Are They the Same?
Kahlert C
Cancer Res; 2019 May; 79(10):2462-2465. PubMed ID: 31043377
[TBL] [Abstract][Full Text] [Related]
10. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities.
Esposito A; Bardelli A; Criscitiello C; Colombo N; Gelao L; Fumagalli L; Minchella I; Locatelli M; Goldhirsch A; Curigliano G
Cancer Treat Rev; 2014 Jun; 40(5):648-55. PubMed ID: 24184333
[TBL] [Abstract][Full Text] [Related]
11. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.
Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2016 Jul; 22(25):5627-41. PubMed ID: 27433079
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biopsy for the Management of Patients with Colorectal Cancer.
Yamada T; Matsuda A; Koizumi M; Shinji S; Takahashi G; Iwai T; Takeda K; Ueda K; Yokoyama Y; Hara K; Hotta M; Matsumoto S; Yoshida H
Digestion; 2019; 99(1):39-45. PubMed ID: 30554222
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer.
Wang J; Han X; Sun Y
Sci China Life Sci; 2017 Apr; 60(4):356-362. PubMed ID: 28063009
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsies in Oncology and the Current Regulatory Landscape.
Strotman LN; Millner LM; Valdes R; Linder MW
Mol Diagn Ther; 2016 Oct; 20(5):429-36. PubMed ID: 27324559
[TBL] [Abstract][Full Text] [Related]
17. [Circulating cell-free serum DNA: significance as a new biomarker for urological malignancies].
Ellinger J; von Rücker A; Bastian PJ; Müller SC
Urologe A; 2010 Sep; 49(9):1131-2, 1134. PubMed ID: 20628864
[TBL] [Abstract][Full Text] [Related]
18. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
Alix-Panabières C; Pantel K
Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
Cabel L; Proudhon C; Mariani P; Tzanis D; Beinse G; Bieche I; Pierga JY; Bidard FC
Eur J Surg Oncol; 2017 May; 43(5):949-962. PubMed ID: 28185687
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics and diagnostic applications of circulating cell-free DNA in colorectal cancer].
Barták BK; Márkus E; Kalmár A; Galamb O; Szigeti K; Nagy ZB; Zsigrai S; Tulassay Z; Dank M; Igaz P; Molnár B
Orv Hetil; 2019 Jul; 160(30):1167-1177. PubMed ID: 31327245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]